Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong Kong

被引:0
|
作者
Ruopeng Xie
Kimberly M. Edwards
Dillon C. Adam
Kathy S. M. Leung
Tim K. Tsang
Shreya Gurung
Weijia Xiong
Xiaoman Wei
Daisy Y. M. Ng
Gigi Y. Z. Liu
Pavithra Krishnan
Lydia D. J. Chang
Samuel M. S. Cheng
Haogao Gu
Gilman K. H. Siu
Joseph T. Wu
Gabriel M. Leung
Malik Peiris
Benjamin J. Cowling
Leo L. M. Poon
Vijaykrishna Dhanasekaran
机构
[1] The University of Hong Kong,School of Public Health, LKS Faculty of Medicine
[2] The University of Hong Kong,HKU
[3] The Hong Kong Polytechnic University,Pasteur Research Pole, School of Public Health, LKS Faculty of Medicine
[4] Hong Kong Science and Technology Park,Department of Health Technology and Informatics
[5] New Territories,Laboratory of Data Discovery for Health
[6] Hong Kong Science and Technology Park,Centre for Immunology & Infection
[7] New Territories,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Hong Kong experienced a surge of Omicron BA.2 infections in early 2022, resulting in one of the highest per-capita death rates of COVID-19. The outbreak occurred in a dense population with low immunity towards natural SARS-CoV-2 infection, high vaccine hesitancy in vulnerable populations, comprehensive disease surveillance and the capacity for stringent public health and social measures (PHSMs). By analyzing genome sequences and epidemiological data, we reconstructed the epidemic trajectory of BA.2 wave and found that the initial BA.2 community transmission emerged from cross-infection within hotel quarantine. The rapid implementation of PHSMs suppressed early epidemic growth but the effective reproduction number (Re) increased again during the Spring festival in early February and remained around 1 until early April. Independent estimates of point prevalence and incidence using phylodynamics also showed extensive superspreading at this time, which likely contributed to the rapid expansion of the epidemic. Discordant inferences based on genomic and epidemiological data underscore the need for research to improve near real-time epidemic growth estimates by combining multiple disparate data sources to better inform outbreak response policy.
引用
收藏
相关论文
共 50 条
  • [1] Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong Kong
    Xie, Ruopeng
    Edwards, Kimberly M.
    Adam, Dillon C.
    Leung, Kathy S. M.
    Tsang, Tim K.
    Gurung, Shreya
    Xiong, Weijia
    Wei, Xiaoman
    Ng, Daisy Y. M.
    Liu, Gigi Y. Z.
    Krishnan, Pavithra
    Chang, Lydia D. J.
    Cheng, Samuel M. S.
    Gu, Haogao
    Siu, Gilman K. H.
    Wu, Joseph T.
    Leung, Gabriel M.
    Peiris, Malik
    Cowling, Benjamin J.
    Poon, Leo L. M.
    Dhanasekaran, Vijaykrishna
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [2] Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
    Jonathan J. Lau
    Samuel M. S. Cheng
    Kathy Leung
    Cheuk Kwong Lee
    Asmaa Hachim
    Leo C. H. Tsang
    Kenny W. H. Yam
    Sara Chaothai
    Kelvin K. H. Kwan
    Zacary Y. H. Chai
    Tiffany H. K. Lo
    Masashi Mori
    Chao Wu
    Sophie A. Valkenburg
    Gaya K. Amarasinghe
    Eric H. Y. Lau
    David S. C. Hui
    Gabriel M. Leung
    Malik Peiris
    Joseph T. Wu
    Nature Medicine, 2023, 29 : 348 - 357
  • [3] Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
    Lau, Jonathan J.
    Cheng, Samuel M. S.
    Leung, Kathy
    Lee, Cheuk Kwong
    Hachim, Asmaa
    Tsang, Leo C. H.
    Yam, Kenny W. H.
    Chaothai, Sara
    Kwan, Kelvin K. H.
    Chai, Zacary Y. H.
    Lo, Tiffany H. K.
    Mori, Masashi
    Wu, Chao
    Valkenburg, Sophie A.
    Amarasinghe, Gaya K.
    Lau, Eric H. Y.
    Hui, David S. C.
    Leung, Gabriel M.
    Peiris, Malik
    Wu, Joseph T.
    NATURE MEDICINE, 2023, 29 (02) : 348 - +
  • [4] Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January-March 2022
    Mefsin, Yonatan M.
    Chen, Dongxuan
    Bond, Helen S.
    Lin, Yun
    Cheung, Justin K.
    Wong, Jessica Y.
    Ali, Sheikh Taslim
    Lau, Eric H. Y.
    Wu, Peng
    Leung, Gabriel M.
    Cowling, Benjamin J.
    EMERGING INFECTIOUS DISEASES, 2022, 28 (09) : 1856 - 1858
  • [5] Serum neutralisation of the SARS-CoV-2 omicron sublineage BA.2
    Chen, Lin-Lei
    Chu, Allen Wing-Ho
    Zhang, Ricky Rui-Qi
    Hung, Ivan Fan-Ngai
    To, Kelvin Kai-Wang
    LANCET MICROBE, 2022, 3 (06): : E404 - E404
  • [6] Virological features and pathogenicity of SARS-CoV-2 Omicron BA.2
    Chan, Jasper Fuk-Woo
    Hu, Bingjie
    Chai, Yue
    Shuai, Huiping
    Liu, Huan
    Shi, Jialu
    Liu, Yuanchen
    Yoon, Chaemin
    Zhang, Jinjin
    Hu, Jing-Chu
    Hou, Yuxin
    Huang, Xiner
    Yuen, Terrence Tsz-Tai
    Zhu, Tianrenzheng
    Li, Wenjun
    Cai, Jian-Piao
    Luo, Cuiting
    Yip, Cyril Chik-Yan
    Zhang, Anna Jinxia
    Zhou, Jie
    Yuan, Shuofeng
    Zhang, Bao-Zhong
    Huang, Jian-Dong
    Kai-Wang, Kelvin
    Yuen, Kwok-Yung
    Chu, Hin
    CELL REPORTS MEDICINE, 2022, 3 (09)
  • [7] Author Correction: Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
    Jonathan J. Lau
    Samuel M. S. Cheng
    Kathy Leung
    Cheuk Kwong Lee
    Asmaa Hachim
    Leo C. H. Tsang
    Kenny W. H. Yam
    Sara Chaothai
    Kelvin K. H. Kwan
    Zacary Y. H. Chai
    Tiffany H. K. Lo
    Masashi Mori
    Chao Wu
    Sophie A. Valkenburg
    Gaya K. Amarasinghe
    Eric H. Y. Lau
    David S. C. Hui
    Gabriel M. Leung
    Malik Peiris
    Joseph T. Wu
    Nature Medicine, 2024, 30 : 305 - 305
  • [8] Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
    Ryuta Uraki
    Maki Kiso
    Shun Iida
    Masaki Imai
    Emi Takashita
    Makoto Kuroda
    Peter J. Halfmann
    Samantha Loeber
    Tadashi Maemura
    Seiya Yamayoshi
    Seiichiro Fujisaki
    Zhongde Wang
    Mutsumi Ito
    Michiko Ujie
    Kiyoko Iwatsuki-Horimoto
    Yuri Furusawa
    Ryan Wright
    Zhenlu Chong
    Seiya Ozono
    Atsuhiro Yasuhara
    Hiroshi Ueki
    Yuko Sakai-Tagawa
    Rong Li
    Yanan Liu
    Deanna Larson
    Michiko Koga
    Takeya Tsutsumi
    Eisuke Adachi
    Makoto Saito
    Shinya Yamamoto
    Masao Hagihara
    Keiko Mitamura
    Tetsuro Sato
    Masayuki Hojo
    Shin-ichiro Hattori
    Kenji Maeda
    Riccardo Valdez
    Moe Okuda
    Jurika Murakami
    Calvin Duong
    Sucheta Godbole
    Daniel C. Douek
    Ken Maeda
    Shinji Watanabe
    Aubree Gordon
    Norio Ohmagari
    Hiroshi Yotsuyanagi
    Michael S. Diamond
    Hideki Hasegawa
    Hiroaki Mitsuya
    Nature, 2022, 607 : 119 - 127
  • [9] Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
    Yamasoba, Daichi
    Kimura, Izumi
    Nasser, Hesham
    Morioka, Yuhei
    Nao, Naganor
    Ito, Jumpei
    Uriu, Keiya
    Tsuda, Masumi
    Zahradnik, Jiri
    Shirakawa, Kotaro
    Suzuki, Rigel
    Kishimoto, Mai
    Kosugi, Yusuke
    Kobiyama, Kouji
    Hara, Teppei
    Toyoda, Mako
    Tanaka, Yuri L.
    Butlertanaka, Erika P.
    Shimizu, Ryo
    Ito, Hayato
    Wang, Lei
    Oda, Yoshitaka
    Orba, Yasuko
    Sasaki, Michihito
    Nagata, Kayoko
    Yoshimatsu, Kumiko
    Asakura, Hiroyuki
    Nagashima, Mami
    Sadamasu, Kenji
    Yoshimura, Kazuhisa
    Kuramochi, Jin
    Seki, Motoaki
    Fujiki, Ryoji
    Kaneda, Atsushi
    Shimada, Tadanaga
    Nakada, Taka-aki
    Sakao, Seiichiro
    Suzuki, Takuji
    Ueno, Takamasa
    Takaori-Kondo, Akifumi
    Ishii, Ken J.
    Schreiber, Gideon
    Sawa, Hirofumi
    Saito, Akatsuki
    Irie, Takashi
    Tanaka, Shinya
    Matsuno, Keita
    Fukuhara, Takasuke
    Ikeda, Terumasa
    Sato, Kei
    CELL, 2022, 185 (12) : 2103 - +
  • [10] Immune correlates with disease severity in older patients after SARS-CoV-2 BA.2 infection in Hong Kong
    Liu, Na
    Zhou, Runhong
    Tam, Anthony Raymond
    Chu, Wing- Ming
    Yang, Dawei
    Huang, Haode
    Peng, Qiaoli
    Du, Zhenglong
    Chen, Bohao
    To, Kelvin Kai-Wang
    Chen, Zhiwei
    CLINICAL IMMUNOLOGY, 2024, 259